Physician

Allen Chiang, M.D.

According to 2025 Medicare claims, Allen Chiang, M.D. (NPI: 1326212960) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 18017-9412.

Chiang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,696 traditional Medicare patients, billed 42,295 HCPCS/CPT codes, and received $6,224,008 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 374 prescription claims across 145 beneficiaries totaling $39,358 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 109 records totaling $393,772. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,240,690 to $6,224,008. Similarly, Part D prescription costs have risen steadily, from $20,701 to $39,358. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.6M$7.1M2015 Medicare payment: $3,240,690 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,575,204 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,814,588 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,950,316 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,060,289 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,444,625 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,123,390 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,963,082 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,680,244 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,224,008 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,55715,623$3,240,690
20161,76121,050$4,575,204
20171,97525,720$5,814,588
20182,04629,290$5,950,316
20191,83328,626$6,060,289
20201,69729,080$6,444,625
20211,84032,179$7,123,390
20222,05235,964$6,963,082
20231,95743,952$6,680,244
20241,69642,295$6,224,008

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$52K2015 Drug cost: $20,701 (USD; Tot_Drug_Cst)2016 Drug cost: $33,195 (USD; Tot_Drug_Cst)2017 Drug cost: $36,091 (USD; Tot_Drug_Cst)2018 Drug cost: $41,991 (USD; Tot_Drug_Cst)2019 Drug cost: $33,171 (USD; Tot_Drug_Cst)2020 Drug cost: $36,073 (USD; Tot_Drug_Cst)2021 Drug cost: $38,364 (USD; Tot_Drug_Cst)2022 Drug cost: $47,221 (USD; Tot_Drug_Cst)2023 Drug cost: $51,696 (USD; Tot_Drug_Cst)2024 Drug cost: $39,358 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015124356$20,701
2016141371$33,195
2017148428$36,091
2018164492$41,991
2019161467$33,171
2020166473$36,073
2021161498$38,364
2022170465$47,221
2023185475$51,696
2024145374$39,358

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3354,026$652
67028Injection of drug into eye6773,661$102
92014Established patient complete exam of visual system777844$89
92012Established patient problem focused exam of visual system8602,431$68
92134Imaging of retina1,6485,133$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1136,198$6,351
ProlensaBromfenac Sodium18849$5,993
Bromfenac SodiumBromfenac Sodium17622$2,399
Ketorolac TromethamineKetorolac Tromethamine813,977$1,262
Atropine SulfateAtropine Sulfate12735$594

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$53Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.108$393,719Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allen Chiang, M.D.?

Tedicare shows public-source Medicare data for Allen Chiang, M.D. (NPI 1326212960), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allen Chiang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allen Chiang, M.D.?

Allen Chiang, M.D. is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Allen Chiang, M.D. have Open Payments data?

Allen Chiang, M.D. has 109 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.